|
REDWOOD CITY, CA – JAN. 16, 2007 – Ingenuity Systems announced today that the Genomics
Institute of the Novartis Research Foundation (GNF) has entered into an agreement to renew and
expand the number of licenses to the Ingenuity Pathway Analysis (IPA) software for use in their
research programs.
GNF has used IPA since 2003 and has cited it in published research. John Walker, Group Leader of RNA
Profiling at GNF, co-authored a paper published in Chemistry and Biology titled “Purmorphamine
induces osteogenesis by activation of the hedgehog-signaling pathway,” which describes the successful
use of IPA to determine the mechanism of action of a biologically-active small molecule, which is a
sometimes daunting task.
Ingenuity Pathways Analysis is a software application that enables researchers to model, analyze and
understand the complex biological systems at the core of life science research. IPA is deployed in all
major pharmaceutical companies and hundreds of biotechnology companies and academic institutions
globally. It supports analysis of all high throughput analysis platforms and is used in virtually all areas
of drug discovery and development from target identification and validation to biomarkers, predictive
toxicology, and pharmacogenomics.
Ingenuity Pathways Analysis is available as a web-delivered, hosted, or deployed solution. Fully
functional complimentary trials are available at www.ingenuity.com/trial.
About Ingenuity Systems®
Ingenuity enables researchers to model, analyze and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for biologists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan. www.ingenuity.com.
Contact:
Heidi Bullock
Director, Marketing
Ingenuity Systems
650.381.5150
Holli Dickson
Account Supervisor
Porter Novelli Life Sciences
858.527.3495
> View as
PDF 
|
